This inventor holds 2 USPTO granted patents. Top assignee: North Carolina State University. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: W Steve McCall: Innovator in Bacterial Biofilm Inhibition
Introduction
W Steve McCall is a notable inventor based in Munich, Germany. He has made significant contributions to the field of microbial growth inhibition, particularly through his innovative work on imidazole derivatives. With a total of 2 patents, McCall's research focuses on addressing critical challenges in bacterial biofilm formation.
Latest Patents
McCall's latest patents include the "Inhibition of bacterial biofilms and microbial growth with imidazole derivatives." This patent discloses imidazole derivative compounds that are useful in inhibiting the formation of biofilms and microbial growth. The patent also covers compositions, devices, and methods that utilize these compounds, showcasing the practical applications of his research.
Career Highlights
W Steve McCall is affiliated with North Carolina State University, where he continues to advance his research in microbial inhibition. His work has garnered attention for its potential impact on healthcare and environmental applications.
Collaborations
Some of McCall's notable coworkers include Christian Melander and Zhaoming Su, who have collaborated with him on various research projects.
Conclusion
W Steve McCall's innovative work in the field of bacterial biofilm inhibition highlights the importance of research in combating microbial growth. His contributions through patents and collaborations continue to pave the way for advancements in this critical area of study.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile